Aldeyra Therapeutics (NASDAQ:ALDX) announced on Thursday that its investigational new drug reproxalap ophthalmic solution for patients with allergic...
Related Keywords
Todd Brady , Drug Administration , Aldeyra Therapeutics , New Drug Application , Drug User Fee Act ,
comparemela.com © 2020. All Rights Reserved.